Luke Joseph Laffin

Luke Joseph Laffin

Auto-generated profile, based on publicly available information

Luke Joseph Laffin

Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
GMGillian Murtagh
Gillian Murtagh
LLLuke J. Laffin
Luke J. Laffin
JBJohn F. Beshai
John F. Beshai
FMFrancesco Maffessanti
Francesco Maffessanti
CBCatherine A. Bonham
Catherine A. Bonham
APAmit Patel
Amit Patel
Background—: Cardiac sarcoidosis is associated with an increased risk of heart failure and sudden death, but its risk in patients with preserved left ventricular ejection fraction is unknown. Using cardiovascular magnetic resonance in patients with extracardiac sarcoidosis and preserved left ventricular ejection fraction, we sought to (1) determine the prevalence of cardiac sarcoidosis or associated myocardial damage, defined by the presence of late gadolinium enhancement (LGE), (2) quantify their risk of death/ventricular tachycardia (VT), and (3) identify imaging-based covariates that predict who is at greatest risk of death/VT. Methods and Results—: Parameters of left and right ventricular function and LGE burden were measured in 205 patients with left ventricular ejection fraction >50% and extracardiac sarcoidosis who underwent cardiovascular magnetic resonance for LGE evaluation. The association between covariates and death/VT in the entire group and within the LGE+ group was determined using Cox proportional hazard models and time-dependent receiver–operator curves analysis. Forty-one of 205 patients (20%) had LGE; 12 of 205 (6%) died or had VT during follow-up; of these, 10 (83%) were in the LGE+ group. In the LGE+ group (1) the rate of death/VT per year was >20× higher than LGE− (4.9 versus 0.2%, P <0.01); (2) death/VT were associated with a greater burden of LGE (14±11 versus 5±5%, P <0.01) and right ventricular dysfunction (right ventricular EF 45±12 versus 53±28%, P =0.04). LGE burden was the best predictor of death/VT (area under the receiver-operating characteristics curve, 0.80); for every 1% increase of LGE burden, the hazard of death/VT increased by 8%. Conclusions—: Sarcoidosis patients with LGE are at significant risk for death/VT, even with preserved left ventricular ejection fraction. Increased LGE burden and right ventricular dysfunction can identify LGE+ patients at highest risk of death/VT.

6 December 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
LLLuke J. Laffin
Luke J. Laffin
HKHarvey W. Kaufman
Harvey W. Kaufman
ZCZhen Chen
Zhen Chen
JNJustin K. Niles
Justin K. Niles
AAAndre R. Arellano
Andre R. Arellano
SHStanley L. Hazen
Stanley L. Hazen

29 March 2019 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
MLMichael Laffin
Michael Laffin
HKHamid Tayebi Khosroshahi
Hamid Tayebi Khosroshahi
HPHeekuk Park
Heekuk Park
LLLuke J. Laffin
Luke J. Laffin
KMKaren Madsen
Karen Madsen
NVNosratola D. Vaziri
Nosratola D. Vaziri

27 September 2016 in Echocardiography
Verified
Journal Article
Closed access
PDF file
GMGillian Murtagh
Gillian Murtagh
LLLuke J. Laffin
Luke J. Laffin
KPKershaw V. Patel
Kershaw V. Patel
APAmit V. Patel
Amit V. Patel
CBCatherine A. Bonham
Catherine A. Bonham
APAmit Patel
Amit Patel

1 February 2020 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
NNNikhil Narang
Nikhil Narang
BCBen Chung
Ben Chung
ANAnn Nguyen
Ann Nguyen
RKRohan J. Kalathiya
Rohan J. Kalathiya
LLLuke J. Laffin
Luke J. Laffin
NUNir Uriel
Nir Uriel